Advanced pharmacology
HH is a 68 yo M who has been admitted to the medical ward with community-acquired pneumonia for the past 3 days. His PMH is significant for COPD, HTN, hyperlipidemia, and diabetes. He remains on empiric antibiotics, which include ceftriaxone 1 g IV qday (day 3) and azithromycin 500 mg IV qday (day 3). Since admission, his clinical status has improved, with decreased oxygen requirements. He is not tolerating a diet at this time with complaints of nausea and vomiting. Advanced pharmacology
Ht: 5’8” Wt: 89 kg
Allergies: Penicillin (rash)
You are required to include at least three evidence based peer-reviewed journal articles or evidenced based guidelines which relates to this case to support your diagnostics and differentials diagnoses. Be sure to use correct APA 6th edition formatting. 2 pages
Case Study 2
A 46-year-old, 230lb woman with a family history of breast cancer. She is up to date on yearly mammograms. She has a history of HTN. She complains of hot flushing, night sweats, and genitourinary symptoms. She had felt well until 1 month ago and she presented to her gynecologist for her annual gyn examination and to discuss her symptoms. She has a history of ASCUS about 5 years ago on her pap, other than that, Pap smears have been normal. Home medications are Norvasc 10mg qd and HCTZ 25mg qd. Her BP today is 150/90. She has regular monthly menstrual cycles. Her LMP was 1 month ago. Advanced pharmacology
You are required to include at least three evidence based peer-reviewed journal articles or evidenced based guidelines which relates to this case to support your diagnostics and differentials diagnoses. Be sure to use correct APA 6th edition formatting. 2 pages
Women’s and Men’s Health/Infections and Hematologic Systems
As an advanced practice nurse, you will likely encounter many disorders associated with women’s and men’s health, such as hormone deficiencies, cancers, and other functional and structural abnormalities. Disorders such as these not only result in physiological consequences but also psychological consequences, such as embarrassment, guilt, or profound disappointment for patients. For these reasons, the provider-patient relationship must be carefully managed. During evaluations, patients must feel comfortable answering questions so that you, as a key health-care provider, will be able to diagnose and recommend appropriate treatment options. Advanced practice nurses must be able to educate patients on these disorders and help relieve associated stigmas and concerns. Advanced pharmacology
This week, you examine women’s and men’s health concerns as well as the types of drugs used to treat disorders that affect women’s and men’s health. You also explore how to treat aspects of these disorders on other health systems.
Discussion: Women’s and Men’s Health, Infectious Disease, and Hematologic Disorders
As an advanced practice nurse, you will likely experience patient encounters with complex comorbidities. For example, consider a female patient who is pregnant who also presents with hypertension, diabetes, and has a recent tuberculosis infection. How might the underlying pathophysiology of these conditions affect the pharmacotherapeutics you might recommend to help address your patient’s health needs? What education strategies might you recommend for ensuring positive patient health outcomes? Advanced pharmacology
For this Discussion, you will be assigned 2 patient case studies and will consider how to address the patient’s current drug therapy plans. You will then suggest recommendations on how to revise these drug therapy plans to ensure effective, safe, and quality patient care for positive patient health outcomes.
Post a brief description of your patient’s health needs from each patient case study. Be specific. Then, explain the type of treatment regimen you would recommend for treating your patient, including the choice or pharmacotherapeutics you would recommend and explain why. Be sure to justify your response. Explain a patient education strategy you might recommend for assisting your patient with the management of their health needs. Be specific and provide examples. Advanced pharmacology
http://informahealthcare.com/tam ISSN: 1368-5538 (print), 1473-0790 (electronic)
Aging Male, 2015; 18(1): 5–15 ! 2015 The Author(s). Published by Taylor & Francis. DOI: 10.3109/13685538.2015.1004049
O R I G I N A L A R T I C L E
Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men
Bruno Lunenfeld1, George Mskhalaya2, Michael Zitzmann3, Stefan Arver4, Svetlana Kalinchenko5, Yuliya Tishova5, and Abraham Morgentaler6
1Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, 2Department of Andrology, Center for Reproductive Medicine MAMA, Moscow, Advanced pharmacology
Russian Federation, 3
Centre for Reproductive Medicine and Andrology, University Clinics Muenster, Münster, Germany, 4
Centre for Andrology and
Sexual Medicine, Karolinska University Hospital and Karolinska Institutet Stockholm, Stockholm, Sweden, 5Clinical Endocrinology, Peoples’
Friendship University of Russia, Moscow, Russian Federation, and 6Men’s Health Boston, Harvard Medical School, Boston, MA, USA
ORDER A PLAGIARISM FREE PAPER NOW
Abstract
Hypogonadism or Testosterone Deficiency (TD) in adult men as defined by low levels of serum testosterone accompanied by characteristic symptoms and/or signs as detailed further on can be found in long-recognized clinical entities such as Klinefelter syndrome, Kallmann syndrome, pituitary or testicular disorders, as well as in men with idiopathic, metabolic or iatrogenic conditions that result in testosterone deficiency. These recommendations do not encompass the full range of pathologies leading to hypogonadism (testosterone deficiency), but instead focus on the clinical spectrum of hypogonadism related to metabolic and idiopathic disorders that contribute to the majority of cases that occur in adult men. Advanced pharmacology
Keywords
Hypogonadism, late-onset, men, testosterone deficiency, testosterone
History
Received 25 December 2014 Accepted 26 December 2014 Published online 6 February 2015
Introduction
The International Society for the Study of the Aging Male
(ISSAM) Hypogonadism panel consists of a multidisciplinary
group of experts, including urologists, endocrinologists,
andrologists and internists with various subspecialties. The
first recommendations were published in 2002 [1]. Due to the
need for ongoing re-evaluation of the information presented in
the recommendations they were revised in 2005 [2]. Clinical
guidelines present the best evidence available to the experts at
the time of writing, but as knowledge increased they were
again updated in 2009 [3]. Since then a great amount of new Advanced pharmacology
information accumulated which encouraged us in 2013 to
prepare a draft proposal for a further update [4]. This proposal
was presented at the VII ISSAM congress in Moscow. A final
form was presented at the ISSAM congress in Almaty,
Kazakhstan, and the final version was accepted by consensus.
It must however be remembered that recommendations can
never replace clinical expertise. Treatment decisions, selec-
tion of treatment protocols or choice of products for
individual patients must take into account patients’ personal
needs and wishes. The multidisciplinary group of experts
received no corporate funding or remuneration for preparing
these recommendations. Advanced pharmacology
Hypogonadism or Testosterone Deficiency (TD) in adult
men as defined by low levels of serum testosterone
accompanied by characteristic symptoms and/or signs as
detailed further on can be found in long-recognized clinical
entities such as Klinefelter syndrome, Kallmann syndrome,
pituitary or testicular disorders, as well as in men with
idiopathic, metabolic or iatrogenic conditions that result in
testosterone deficiency. These recommendations do not
encompass the full range of pathologies leading to hypogonad-
ism (testosterone deficiency), but instead focus on the clinical
spectrum of hypogonadism related to metabolic and idiopathic
disorders that contribute to the majority of cases that occur in
adult men Advanced pharmacology
Also check: Applying Quality Management in Healthcare